{"id":"https://openalex.org/W6997098562","doi":null,"title":"An Ultra Long-acting Bictegravir Prodrug Nanocrystal with a Shape-shifting Pharmacokinetic Tail","display_name":"An Ultra Long-acting Bictegravir Prodrug Nanocrystal with a Shape-shifting Pharmacokinetic Tail","alternate_titles":[],"publication_year":2024,"publication_date":"2024-05-04","ids":{"openalex":"https://openalex.org/W6997098562"},"language":"en","primary_location":{"id":"pmh:oai:digitalcommons.unmc.edu:etd-1851","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.unmc.edu/context/etd/article/1851/viewcontent/COMPLIANT_unmc_etd_1844.pdf","pdf_url":"https://digitalcommons.unmc.edu/context/etd/article/1851/viewcontent/Mohammad_20Ullah_20Nayan.pdf","source":{"id":"https://openalex.org/S7407097584","display_name":"DigitalCommons@UNMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I59130452","host_organization_name":"University of Nebraska Medical Center","host_organization_lineage":["https://openalex.org/I59130452"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Theses & Dissertations","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W6997098562"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://digitalcommons.unmc.edu/context/etd/article/1851/viewcontent/Mohammad_20Ullah_20Nayan.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028310946","display_name":"Mohammad Ullah Nayan","orcid":"https://orcid.org/0000-0003-0634-8879","observed_orcids":["https://orcid.org/0000-0003-0634-8879"]},"institutions":[{"id":"https://openalex.org/I114395901","display_name":"University of Nebraska\u2013Lincoln","ror":"https://ror.org/043mer456","country_code":"US","type":"education","lineage":["https://openalex.org/I114395901"]},{"id":"https://openalex.org/I2802450327","display_name":"University of Nebraska System","ror":"https://ror.org/0238rvs44","country_code":"US","type":"education","lineage":["https://openalex.org/I2802450327"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Nayan, Mohammad Ullah","raw_affiliation_strings":["University of Nebraska , 2024"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska , 2024","institution_ids":["https://openalex.org/I114395901","https://openalex.org/I2802450327"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5028310946"],"corresponding_institution_ids":["https://openalex.org/I114395901","https://openalex.org/I2802450327"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9185000061988831,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9185000061988831,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.03779999911785126,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.016699999570846558,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bictegravir","display_name":"bictegravir","score":0.9760000109672546},{"id":"https://openalex.org/keywords/long-acting-antiretroviral-therapy","display_name":"long-acting antiretroviral therapy","score":0.8970000147819519},{"id":"https://openalex.org/keywords/nanocrystals","display_name":"nanocrystals","score":0.7799999713897705},{"id":"https://openalex.org/keywords/nanoparticle-suspensions","display_name":"nanoparticle suspensions","score":0.7409999966621399},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.39500001072883606},{"id":"https://openalex.org/keywords/lenacapavir","display_name":"lenacapavir","score":0.8489999771118164}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7962999939918518},{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.7559000253677368},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6585999727249146},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.5641999840736389},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5437999963760376},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5285999774932861},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.43689998984336853},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4275999963283539},{"id":"https://openalex.org/C197746943","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Microbicide","level":3,"score":0.4271000027656555},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4056999981403351},{"id":"https://openalex.org/C2779496540","wikidata":"https://www.wikidata.org/wiki/Q7239230","display_name":"Pre-exposure prophylaxis","level":5,"score":0.39010000228881836},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.3792000114917755},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.3772999942302704},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3716999888420105},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.35670000314712524},{"id":"https://openalex.org/C140206745","wikidata":"https://www.wikidata.org/wiki/Q5308895","display_name":"Drug holiday","level":3,"score":0.3529999852180481},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.35199999809265137},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35040000081062317},{"id":"https://openalex.org/C149172746","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Efficacy","level":3,"score":0.3181000053882599},{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.30869999527931213},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30329999327659607},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.3012000024318695},{"id":"https://openalex.org/C12914427","wikidata":"https://www.wikidata.org/wiki/Q7933612","display_name":"Viral shedding","level":3,"score":0.2563000023365021},{"id":"https://openalex.org/C2987276129","wikidata":"https://www.wikidata.org/wiki/Q12140","display_name":"Drug administration","level":2,"score":0.2540000081062317}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:digitalcommons.unmc.edu:etd-1851","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.unmc.edu/context/etd/article/1851/viewcontent/COMPLIANT_unmc_etd_1844.pdf","pdf_url":"https://digitalcommons.unmc.edu/context/etd/article/1851/viewcontent/Mohammad_20Ullah_20Nayan.pdf","source":{"id":"https://openalex.org/S7407097584","display_name":"DigitalCommons@UNMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I59130452","host_organization_name":"University of Nebraska Medical Center","host_organization_lineage":["https://openalex.org/I59130452"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Theses & Dissertations","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:digitalcommons.unmc.edu:etd-1851","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.unmc.edu/context/etd/article/1851/viewcontent/COMPLIANT_unmc_etd_1844.pdf","pdf_url":"https://digitalcommons.unmc.edu/context/etd/article/1851/viewcontent/Mohammad_20Ullah_20Nayan.pdf","source":{"id":"https://openalex.org/S7407097584","display_name":"DigitalCommons@UNMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I59130452","host_organization_name":"University of Nebraska Medical Center","host_organization_lineage":["https://openalex.org/I59130452"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Theses & Dissertations","raw_type":"text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W6997098562.pdf","grobid_xml":"https://content.openalex.org/works/W6997098562.grobid-xml"},"referenced_works_count":90,"referenced_works":["https://openalex.org/W1552317649","https://openalex.org/W1848709375","https://openalex.org/W1980136429","https://openalex.org/W1986802370","https://openalex.org/W2000913691","https://openalex.org/W2008994596","https://openalex.org/W2011190628","https://openalex.org/W2015768353","https://openalex.org/W2022492365","https://openalex.org/W2031611834","https://openalex.org/W2056424254","https://openalex.org/W2075144974","https://openalex.org/W2092299612","https://openalex.org/W2106123030","https://openalex.org/W2106408660","https://openalex.org/W2117057469","https://openalex.org/W2121737909","https://openalex.org/W2154854455","https://openalex.org/W2164099498","https://openalex.org/W2168251450","https://openalex.org/W2169063360","https://openalex.org/W2172275755","https://openalex.org/W2290010664","https://openalex.org/W2293854741","https://openalex.org/W2298072787","https://openalex.org/W2318289184","https://openalex.org/W2333399282","https://openalex.org/W2394662221","https://openalex.org/W2523305619","https://openalex.org/W2527103551","https://openalex.org/W2558446330","https://openalex.org/W2586083164","https://openalex.org/W2588766650","https://openalex.org/W2594880325","https://openalex.org/W2602409846","https://openalex.org/W2729726193","https://openalex.org/W2738136433","https://openalex.org/W2738541296","https://openalex.org/W2752494178","https://openalex.org/W2754744356","https://openalex.org/W2796958178","https://openalex.org/W2804301217","https://openalex.org/W2883638714","https://openalex.org/W2894709229","https://openalex.org/W2896673830","https://openalex.org/W2901789135","https://openalex.org/W2945672866","https://openalex.org/W2966124758","https://openalex.org/W2969584959","https://openalex.org/W2981566974","https://openalex.org/W2982097452","https://openalex.org/W3009494891","https://openalex.org/W3010513804","https://openalex.org/W3015019101","https://openalex.org/W3030006426","https://openalex.org/W3030616052","https://openalex.org/W3036716176","https://openalex.org/W3040374393","https://openalex.org/W3040681310","https://openalex.org/W3043420940","https://openalex.org/W3093404578","https://openalex.org/W3108345840","https://openalex.org/W3111050887","https://openalex.org/W3126829155","https://openalex.org/W3127596325","https://openalex.org/W3138725832","https://openalex.org/W3157916043","https://openalex.org/W3172828453","https://openalex.org/W3175233370","https://openalex.org/W3177982925","https://openalex.org/W3179884350","https://openalex.org/W3188123112","https://openalex.org/W3190424399","https://openalex.org/W3193434325","https://openalex.org/W3194324753","https://openalex.org/W3205090773","https://openalex.org/W3206131309","https://openalex.org/W3207677309","https://openalex.org/W4200502653","https://openalex.org/W4226116413","https://openalex.org/W4254832362","https://openalex.org/W4280564133","https://openalex.org/W4281706677","https://openalex.org/W4282943461","https://openalex.org/W4288063375","https://openalex.org/W4289529799","https://openalex.org/W4294368546","https://openalex.org/W4312211076","https://openalex.org/W4366082805","https://openalex.org/W4386733253"],"related_works":["https://openalex.org/W4384023277","https://openalex.org/W3027089325","https://openalex.org/W4409714754","https://openalex.org/W3157916043","https://openalex.org/W7204159976","https://openalex.org/W590937065","https://openalex.org/W4402894660","https://openalex.org/W4384119764","https://openalex.org/W6992476224","https://openalex.org/W3215180580"],"abstract_inverted_index":{"While":[0],"antiretroviral":[1,272,352],"therapy":[2,20],"(ART)":[3],"has":[4,41,117,185,242],"significantly":[5],"reduced":[6],"human":[7],"immunodeficiency":[8],"virus":[9],"type":[10],"one":[11],"(HIV-1)":[12],"co-morbidities":[13],"and":[14,28,51,57,71,76,101,120,140,149,161,175,192,219,331,342,351,358,369,467,480,494],"mortality,":[15],"adherence":[16],"to":[17,25,81,122,125,170,188,201,224,316,356,418],"daily":[18,126],"oral":[19,127],"remains":[21],"a":[22,84,108,280,304,312,319,326,363,388,406,430,436,458,492,501],"key":[23,145],"barrier":[24,315],"all":[26],"therapeutic":[27],"preventative":[29],"outcomes.":[30,60],"Over":[31],"the":[32,35,144,152,168,193,202,285,376,421,455,489],"past":[33],"years,":[34],"emergence":[36,194],"of":[37,86,195,222,287,294,321,339,392,398,409,439],"long-acting":[38],"(LA)":[39],"ART":[40,62,239,262],"gained":[42],"considerable":[43],"enthusiasm":[44],"amongst":[45],"people":[46],"living":[47],"with":[48,138,167,252,277,311,500],"HIV":[49],"(PLWH)":[50],"could":[52,63,179],"potentially":[53,180],"simplify":[54],"dosing":[55,154],"regimens":[56],"improve":[58,65],"treatment":[59,286],"LA":[61,88,238,271,297],"also":[64],"drug":[66,74,196,209,216,347,414],"adherence,":[67],"reduce":[68],"viral":[69,73,176,234],"transmission,":[70],"limit":[72],"resistance":[75,223],"systemic":[77],"toxicities.":[78],"In":[79],"response":[80],"these":[82,292],"needs,":[83],"combination":[85],"two":[87],"injectable":[89,113,203,296],"nanocrystalline":[90],"drugs":[91],"(CABENUVA)":[92],"was":[93,427],"recently":[94],"approved":[95,119,244],"for":[96,129,147,245,284,382,423,457,491],"bimonthly":[97,109],"administration":[98,247],"in":[99,133,227,248,400,477],"adults":[100,251],"adolescents":[102],"who":[103,135,229,257],"are":[104],"virologically":[105],"suppressed.":[106],"Further,":[107],"extended-release":[110],"cabotegravir":[111],"(CAB)":[112],"suspension":[114],"(APPRETUDE)":[115],"monotherapy":[116],"been":[118,186,243],"shown":[121,187],"be":[123,275],"superior":[124],"Truvada":[128],"pre-exposure":[130],"prophylaxis":[131],"(PrEP)":[132],"men":[134,139],"have":[136,230,258],"sex":[137],"transgender":[141],"women.":[142],"However,":[143,264],"challenge":[146],"CABENUVA":[148],"APRETUDE":[150],"is":[151,268],"frequent":[153],"that":[155,273,449],"exerts":[156],"pressure":[157],"on":[158],"healthcare":[159],"workers":[160],"allied":[162],"facilities.":[163],"This":[164,426],"limitation,":[165],"combined":[166,276],"need":[169],"synchronize":[171],"CD4+":[172],"T":[173],"cell":[174],"load":[177],"tests,":[178],"affect":[181],"compliance.":[182],"Poor":[183],"compliance":[184],"increase":[189],"infection":[190,256],"rates":[191],"resistance.":[197],"Other":[198],"barriers":[199],"linked":[200],"formulations":[204],"include":[205],"prolonged":[206,445],"subtherapeutic":[207],"terminal":[208],"decay":[210],"curves":[211],"[pharmacokinetic":[212],"(PK)":[213],"tail]":[214],"following":[215],"regimen":[217,283],"cessation":[218],"increased":[220],"risk":[221],"rilpivirine,":[225],"especially":[226],"patients":[228],"much":[231],"higher":[232],"baseline":[233],"loads.":[235],"Another":[236],"potent":[237,305],"SUNLENCA":[240,278],"(lenacapavir)":[241],"six-monthly":[246],"heavily":[249],"treatment-experienced":[250],"multidrug-resistant":[253],"(MDR)":[254],"HIV-1":[255,288],"failed":[259],"their":[260],"current":[261],"regimen.":[263],"at":[265,452],"present,":[266],"there":[267],"no":[269],"other":[270],"can":[274],"as":[279,362],"complete":[281],"synchronous":[282],"infection.":[289],"To":[290],"overcome":[291],"challenges":[293],"existing":[295],"ARVs,":[298],"we":[299],"transformed":[300],"native":[301],"bictegravir":[302],"(BIC),":[303],"integrase":[306],"strand":[307],"transfer":[308],"inhibitor":[309],"(INSTI)":[310],"high":[313],"genetic":[314],"resistance,":[317],"into":[318],"library":[320],"ester":[322],"prodrugs.":[323],"These":[324],"included":[325],"BIC":[327,332,372,395,410,447,470,497],"stearate":[328],"monomer":[329],"(M2BIC)":[330],"octadecanedioate":[333],"dimer":[334],"(MXBIC).":[335],"Surfactant-stabilized":[336],"aqueous":[337],"nanosuspensions":[338],"M2BIC":[340],"(NM2BIC)":[341],"MXBIC":[343],"(NMXBIC)":[344],"enhanced":[345],"intracellular":[346],"uptake,":[348],"retention,":[349],"release,":[350],"activities.":[353],"When":[354],"administered":[355],"rodents":[357],"nonhuman":[359],"primates":[360],"(NHP)":[361],"single":[364,389],"intramuscular":[365],"(IM)":[366],"dose":[367,397,438],"NMXBIC":[368,399],"NM2BIC":[370,440],"generated":[371],"plasma":[373,446],"concentrations":[374],"above":[375,416,454],"protein-adjusted":[377],"95%":[378],"inhibitory":[379],"concentration":[380],"(PA-IC95)":[381],"six":[383,424],"months":[384],"or":[385,453],"longer.":[386],"Notably,":[387],"IM":[390],"injection":[391,462],"45":[393],"mg/kg":[394],"equivalent":[396],"Sprague":[401],"Dawley":[402],"(SD)":[403],"rats":[404],"provided":[405],"\"plateau\"":[407],"phase":[408],"exposure,":[411],"sustaining":[412],"active":[413],"levels":[415,448,471],"fourteen":[417],"twenty-four":[419],"times":[420],"PA-IC95":[422,456],"months.":[425],"followed":[428],"by":[429],"short":[431,502],"PK":[432,503],"tail.":[433,504],"By":[434],"contrast,":[435],"similar":[437],"produced":[441],"lower":[442],"but":[443],"more":[444],"were":[450,472],"sustained":[451],"year.":[459],"Readily":[460],"detectable":[461],"site":[463],"depot,":[464],"lymphoid,":[465],"mucosal,":[466],"gut":[468],"tissue":[469],"recorded":[473],"without":[474],"adverse":[475],"reactions":[476],"rodents,":[478],"rabbits,":[479],"rhesus":[481],"macaques.":[482],"The":[483],"promising":[484],"preclinical":[485],"data":[486],"sets":[487],"demonstrate":[488],"potential":[490],"tolerable":[493],"safe":[495],"six-month":[496],"prodrug":[498],"formulation":[499]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W6997098562","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-10-10T00:00:00"}
